Three young patients with relapsed T-cell leukemia have now been treated with base-edited T-cells, as part of a "bench-to-bedside" collaboration between University College London (UCL) and Great Ormond Street Hospital for ...
Jun 14, 2023
0
50
The most common screening test for prostate cancer so often returns a false positive result that it's no longer recommended for men older than 70, and it's offered as a personal choice for younger men.
Jun 10, 2023
0
5
A Ludwig Cancer Research study has shown that some molecules previously used to treat hypertension might also help the immune system to better target cancer cells. Reported in the current issue of Nature, these findings could, ...
Jun 7, 2023
0
88
No man wants to hear that he has prostate cancer, but if he is diagnosed he will need to learn about the disease and how it is treated.
Jun 5, 2023
0
4
Patients with early relapsed or refractory large B-cell lymphoma had significantly improved overall survival when treated with the chimeric antigen receptor (CAR) T cell therapy axicabtagene ciloleucel (axi-cel) when compared ...
Jun 5, 2023
0
33
If you came down with a respiratory infection in the spring and it wasn't influenza (flu), COVID-19 or RSV, it may have been a virus you've never heard of.
Jun 1, 2023
0
24
In the five years since the FDA's initial approval of chimeric antigen receptor (CAR) T cell therapy, Penn Medicine has gleaned 20 additional approvals related to drugs and techniques to treat or detect cancer.
May 29, 2023
0
33
Up to 60% of cancer patients receive radiation therapy, but it doesn't always work. Failure of these treatments results from tumor regrowth at the primary tumor site, or when the tumor metastasizes to another part of the ...
May 25, 2023
0
57
Most high income countries, including the U.K., do not have a national prostate cancer screening program, but instead allow men without symptoms to get a prostate-specific antigen (PSA) test if they wish, after talking to ...
May 17, 2023
0
5
Researchers at Children's Hospital of Philadelphia (CHOP) and the University of California, Los Angeles (UCLA) have developed a computational platform capable of discovering tumor antigens derived from alternative RNA splicing, ...
May 17, 2023
0
37
